DCOY
Price
$1.14
Change
-$0.04 (-3.42%)
Updated
Oct 20 closing price
Capitalization
743.64K
Intraday BUY SELL Signals
VOR
Price
$19.03
Change
+$0.99 (+5.49%)
Updated
Oct 20 closing price
Capitalization
1.13B
23 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DCOY vs VOR

DCOY vs VOR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DCOY vs. VOR commentary
Oct 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DCOY is a Hold and VOR is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for DCOY with price predictions
Oct 19, 2026

Momentum Indicator for DCOY turns negative, indicating new downward trend

DCOY saw its Momentum Indicator move below the 0 level on September 28, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 93 similar instances where the indicator turned negative. In 90 of the 93 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for DCOY turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 43 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

DCOY moved below its 50-day moving average on September 24, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DCOY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

DCOY broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for DCOY entered a downward trend on September 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +51.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where DCOY advanced for three days, in 167 of 207 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.172) is normal, around the industry mean (2.978). P/E Ratio (0.010) is within average values for comparable stocks, (-0.692). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (134.267) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. DCOY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DCOY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for VOR with price predictions
Oct 20, 2026

VOR's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for VOR turned positive on October 09, 2026. Looking at past instances where VOR's MACD turned positive, the stock continued to rise in 42 of 47 cases over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where VOR's RSI Oscillator exited the oversold zone, 33 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on VOR as a result. In 76 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.

Following a +5.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where VOR advanced for three days, in 182 of 218 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

VOR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

VOR moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for VOR crossed bearishly below the 50-day moving average on September 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VOR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for VOR entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-5.624) is normal, around the industry mean (3.009). P/E Ratio (0.105) is within average values for comparable stocks, (-1.027). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (129.622) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. VOR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VOR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
DCOY: Fundamental Ratings
DCOY
OUTLOOK RATING
1..100
97
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DCOYVOR
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 28 days ago
81%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 21, 2026
Stock price -- (DCOY: $1.13 vs. VOR: $19.03)
Brand notoriety: DCOY and VOR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DCOY: 3% vs. VOR: 91%
Market capitalization -- DCOY: $743.64K vs. VOR: $1.13B
DCOY [@Biotechnology] is valued at $743.64K. VOR’s [@Biotechnology] market capitalization is $1.13B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.44B. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DCOY’s FA Score shows that 0 FA rating(s) are green while VOR’s FA Score has 2 green FA rating(s).

  • DCOY’s FA Score: 0 green, 5 red.
  • VOR’s FA Score: 2 green, 3 red.
According to our system of comparison, VOR is a better buy in the long-term than DCOY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DCOY’s TA Score shows that 3 TA indicator(s) are bullish while VOR’s TA Score has 6 bullish TA indicator(s).

  • DCOY’s TA Score: 3 bullish, 6 bearish.
  • VOR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VOR is a better buy in the short-term than DCOY.

Price Growth

DCOY (@Biotechnology) experienced а -8.47% price change this week, while VOR (@Biotechnology) price change was -0.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.45%. For the same industry, the average monthly price growth was -16.03%, and the average quarterly price growth was -14.84%.

Reported Earning Dates

VOR is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Biotechnology (-0.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
DCOY
Daily Signal:
Gain/Loss:
VOR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIVN79.711.57
+2.01%
LivaNova PLC
TRST54.731.05
+1.96%
TrustCo Bank Corp
AIG81.881.22
+1.51%
American International Group
RBKB12.740.05
+0.39%
Rhinebeck Bancorp
ARKR4.38-0.03
-0.68%
Ark Restaurants Corp

DCOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, DCOY has been loosely correlated with GRDX. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if DCOY jumps, then GRDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DCOY
1D Price
Change %
DCOY100%
-2.99%
GRDX - DCOY
61%
Loosely correlated
+5.47%
ALXO - DCOY
35%
Loosely correlated
+8.77%
VOR - DCOY
33%
Poorly correlated
+5.49%
SNGX - DCOY
32%
Poorly correlated
+3.17%
ASBP - DCOY
30%
Poorly correlated
+3.69%
More